Functional impact of missense variants in BRCA1 predicted by supervised learning
- PMID: 17305420
- PMCID: PMC1797820
- DOI: 10.1371/journal.pcbi.0030026
Functional impact of missense variants in BRCA1 predicted by supervised learning
Abstract
Many individuals tested for inherited cancer susceptibility at the BRCA1 gene locus are discovered to have variants of unknown clinical significance (UCVs). Most UCVs cause a single amino acid residue (missense) change in the BRCA1 protein. They can be biochemically assayed, but such evaluations are time-consuming and labor-intensive. Computational methods that classify and suggest explanations for UCV impact on protein function can complement functional tests. Here we describe a supervised learning approach to classification of BRCA1 UCVs. Using a novel combination of 16 predictive features, the algorithms were applied to retrospectively classify the impact of 36 BRCA1 C-terminal (BRCT) domain UCVs biochemically assayed to measure transactivation function and to blindly classify 54 documented UCVs. Majority vote of three supervised learning algorithms is in agreement with the assay for more than 94% of the UCVs. Two UCVs found deleterious by both the assay and the classifiers reveal a previously uncharacterized putative binding site. Clinicians may soon be able to use computational classifiers such as those described here to better inform patients. These classifiers can be adapted to other cancer susceptibility genes and systematically applied to prioritize the growing number of potential causative loci and variants found by large-scale disease association studies.
Conflict of interest statement
Figures





Similar articles
-
Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation.J Med Genet. 2004 Jul;41(7):492-507. doi: 10.1136/jmg.2003.015867. J Med Genet. 2004. PMID: 15235020 Free PMC article.
-
A high-throughput functional complementation assay for classification of BRCA1 missense variants.Cancer Discov. 2013 Oct;3(10):1142-55. doi: 10.1158/2159-8290.CD-13-0094. Epub 2013 Jul 18. Cancer Discov. 2013. PMID: 23867111
-
Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis.Cancer Res. 2007 Feb 15;67(4):1494-501. doi: 10.1158/0008-5472.CAN-06-3297. Cancer Res. 2007. PMID: 17308087 Free PMC article.
-
Collective evidence supports neutrality of BRCA1 V1687I, a novel sequence variant in the conserved THV motif of the first BRCT repeat.Breast Cancer Res Treat. 2012 Jul;134(1):435-41. doi: 10.1007/s10549-012-2052-2. Epub 2012 Apr 22. Breast Cancer Res Treat. 2012. PMID: 22527099
-
Detection of protein folding defects caused by BRCA1-BRCT truncation and missense mutations.J Biol Chem. 2003 Dec 26;278(52):53007-16. doi: 10.1074/jbc.M310182200. Epub 2003 Oct 8. J Biol Chem. 2003. PMID: 14534301
Cited by
-
Evaluation of ultra-deep targeted sequencing for personalized breast cancer care.Breast Cancer Res. 2013 Dec 10;15(6):R115. doi: 10.1186/bcr3584. Breast Cancer Res. 2013. PMID: 24326041 Free PMC article.
-
In silico analysis of missense substitutions using sequence-alignment based methods.Hum Mutat. 2008 Nov;29(11):1327-36. doi: 10.1002/humu.20892. Hum Mutat. 2008. PMID: 18951440 Free PMC article.
-
Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine.Front Oncol. 2023 Jan 18;12:1053035. doi: 10.3389/fonc.2022.1053035. eCollection 2022. Front Oncol. 2023. PMID: 36741700 Free PMC article.
-
Impact of BRCA1 BRCT domain missense substitutions on phosphopeptide recognition.Biochemistry. 2011 May 31;50(21):4579-89. doi: 10.1021/bi2003795. Epub 2011 May 10. Biochemistry. 2011. PMID: 21473589 Free PMC article.
-
Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays.Cancer Res. 2010 Jun 15;70(12):4880-90. doi: 10.1158/0008-5472.CAN-09-4563. Epub 2010 Jun 1. Cancer Res. 2010. PMID: 20516115 Free PMC article.
References
-
- Gudmundsdottir K, Ashworth A. The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene. 2006;25:5864–5874. - PubMed
-
- Starita LM, Parvin JD. Substrates of the BRCA1-dependent ubiquitin ligase. Cancer Biol Ther. 2006;5:137–141. - PubMed
-
- Venkitaraman AR. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell. 2002;108:171–182. - PubMed
-
- Nathanson KN, Wooster R, Weber BL. Breast cancer genetics: What we know and what we need. Nat Med. 2001;7:552–556. - PubMed
-
- Szabo CI, Worley T, Monteiro AN. Understanding germ-line mutations in BRCA1. Cancer Biol Ther. 2004;3:515–520. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous